Aethlon Medical, Inc.AEMDNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -19.07% | -40.65% | +1.94% | +95.15% | +304.10% |
| Weighted Average Shares Diluted Growth | -19.07% | -40.65% | +1.94% | +95.15% | +304.10% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -37.48% | -10.75% | -53.52% | -17.23% | +23.47% |
| Book Value per Share Growth | -29.63% | +49.70% | -61.45% | -51.08% | -61.67% |
| Debt Growth | -28.23% | -30.90% | -21.08% | -37.78% | -42.40% |
| R&D Expense Growth | -59.52% | +105.99% | +26.46% | +12.56% | +121.81% |
| SG&A Expenses Growth | -32.65% | -82.38% | +46121.12% | -63.39% | -24.30% |